دورية أكاديمية
أعرض في EDS

Use of corneal cross-linking beyond keratoconus: a systemic literature review.

التفاصيل البيبلوغرافية
العنوان: Use of corneal cross-linking beyond keratoconus: a systemic literature review.
المؤلفون: Manns RPC; Bristol Eye Hospital, University Hospitals Bristol NHS Foundation Trust, Lower Maudlin St., Bristol, BS1 2LX, UK., Achiron A; Bristol Eye Hospital, University Hospitals Bristol NHS Foundation Trust, Lower Maudlin St., Bristol, BS1 2LX, UK.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Knyazer B; Department of Ophthalmology, Soroka University Medical Center, The Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel., Elhaddad O; Bristol Eye Hospital, University Hospitals Bristol NHS Foundation Trust, Lower Maudlin St., Bristol, BS1 2LX, UK.; Faculty of Medicine, Alexandria University, Alexandria, Egypt., Darcy K; Bristol Eye Hospital, University Hospitals Bristol NHS Foundation Trust, Lower Maudlin St., Bristol, BS1 2LX, UK., Yahalomi T; Department of Ophthalmology, Samson Assuta Ashdod Hospital and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Negev, Israel., Tole D; Bristol Eye Hospital, University Hospitals Bristol NHS Foundation Trust, Lower Maudlin St., Bristol, BS1 2LX, UK., Avadhanam VS; Bristol Eye Hospital, University Hospitals Bristol NHS Foundation Trust, Lower Maudlin St., Bristol, BS1 2LX, UK. venkata@avadhanam.in.
المصدر: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie [Graefes Arch Clin Exp Ophthalmol] 2023 Sep; Vol. 261 (9), pp. 2435-2453. Date of Electronic Publication: 2023 Mar 07.
نوع المنشور: Journal Article; Systematic Review
اللغة: English
بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 8205248 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-702X (Electronic) Linking ISSN: 0721832X NLM ISO Abbreviation: Graefes Arch Clin Exp Ophthalmol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Berlin ; New York : Springer-Verlag, c1982-
مواضيع طبية MeSH: Keratitis, Herpetic* , Keratoconus*/diagnosis , Keratoconus*/drug therapy , Photochemotherapy*/methods, Humans ; Collagen/therapeutic use ; Corneal Cross-Linking ; Cross-Linking Reagents/therapeutic use ; Cross-Linking Reagents/pharmacology ; Photosensitizing Agents/therapeutic use ; Riboflavin/therapeutic use ; Ultraviolet Rays
مستخلص: Purpose: The success of corneal collagen cross-linking in altering keratoconus' clinical course has driven a search for further uses of this procedure. This literature review aims to analyze the scientific evidence available for the benefit of cross-linking in the management of ophthalmic diseases other than progressive keratoconus or ectasia induced by corneal refractive procedures.
Methods: A systemic literature review.
Results: We reviewed 97 studies. We found that collagen cross-linking can limit the progression of several other corneal ectasias, thus reducing and limiting the need for keratoplasty. Collagen cross-linking also can reduce the refractive power of the cornea and can be considered for a moderate degree of bacterial keratitis or when the organism is unidentified, which is refractive to antibiotics alone. However, the comparative rarity of these procedures has limited the extent of evidence. In fungal, Acanthamoeba, and herpes virus keratitis, the evidence is inconclusive of the safety and efficacy of cross-linking.
Conclusion: Current clinical data is limited, and laboratory data has not fully correlated with published clinical data.
(© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
References: Vinciguerra R, Pagano L, Borgia A et al (2020) Corneal cross-linking for progressive keratoconus: up to 13 years of follow-up. J Refract Surg 36:838–843. https://doi.org/10.3928/1081597X-20201021-01. (PMID: 10.3928/1081597X-20201021-0133295997)
Godefrooij DA, Mangen MJJ, Chan E et al (2017) Cost-effectiveness analysis of corneal collagen crosslinking for progressive keratoconus. Ophthalmology 124:1485–1495. https://doi.org/10.1016/J.OPHTHA.2017.04.011. (PMID: 10.1016/J.OPHTHA.2017.04.01128532974)
Shetty R, Kumar NR, Pahuja N et al (2018) Outcomes of corneal cross-linking correlate with cone-specific lysyl oxidase expression in patients with keratoconus. Cornea 37:369–374. https://doi.org/10.1097/ICO.0000000000001478. (PMID: 10.1097/ICO.000000000000147829215396)
Yong JJ, Hatch KM (2019) Corneal cross-linking: an effective treatment option for pellucid marginal degeneration. Semin Ophthalmol 34:512–517. https://doi.org/10.1080/08820538.2019.1659832. (PMID: 10.1080/08820538.2019.165983231449434)
Hafezi F, Gatzioufas Z, Seiler TG, Seiler T (2014) Corneal collagen cross-linking for Terrien marginal degeneration. J Refract Surg 30:498–500. https://doi.org/10.3928/1081597X-20140527-02. (PMID: 10.3928/1081597X-20140527-0224892378)
Knyazer B, Krakauer Y, Tailakh MA et al (2020) Accelerated corneal cross-linking as an adjunct therapy in the management of presumed bacterial keratitis: a cohort study. J Refract Surg 36:258–264. https://doi.org/10.3928/1081597X-20200226-02. (PMID: 10.3928/1081597X-20200226-0232267957)
Shreyas Sachdev G, Ramamurthy S, Dandapani R (2020) Photorefractive intrastromal corneal crosslinking for treatment of low myopia: clinical outcomes using the transepithelial approach with supplemental oxygen. J Cataract Refract Surg 46:428–433. https://doi.org/10.1097/j.jcrs.0000000000000073. (PMID: 10.1097/j.jcrs.0000000000000073)
Kanellopoulos AJ, Asimellis G (2014) Long-term safety and efficacy of high-fluence collagen crosslinking of the vehicle cornea in Boston keratoprosthesis type 1. Cornea 33:914–918. https://doi.org/10.1097/ICO.0000000000000176. (PMID: 10.1097/ICO.000000000000017625014143)
Schaub F, Hou Y, Zhang W et al (2021) Corneal crosslinking to regress pathologic corneal neovascularization before high-risk keratoplasty. Cornea 40:147–155. https://doi.org/10.1097/ICO.0000000000002406. (PMID: 10.1097/ICO.000000000000240633395116)
Krueger RR, Ramos-Esteban JC, Kanellopoulos AJ (2008) Staged intrastromal delivery of riboflavin with UVA cross-linking in advanced bullous keratopathy: laboratory investigation and first clinical case. J Refract Surg 24(7). https://doi.org/10.3928/1081597x-20080901-17.
Mamoosa B, Razmjoo H, Peyman A, Ashtari A, Ghafouri I, Moghaddam A (2016) Short-term result of collagen crosslinking in pellucid marginal degeneration. Adv Biomed Res 5(1):194. https://doi.org/10.4103/2277-9175.192732.
Cagil N, Sarac O, Yesilirmak N, Caglayan M, Uysal BS, Tanriverdi B (2019) Transepithelial phototherapeutic keratectomy followed by corneal collagen crosslinking for the treatment of pellucid marginal degeneration: long-term results. Cornea 38(8):980–985. https://doi.org/10.1097/ICO.0000000000002003. (PMID: 10.1097/ICO.000000000000200331107284)
Wollensak G, Spoerl E, Seiler T (2003) Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking. J Cataract Refract Surg 29(9):1780–1785. https://doi.org/10.1016/S0886-3350(03)00407-3. (PMID: 10.1016/S0886-3350(03)00407-314522301)
Spadea L (2010) Corneal collagen cross-linking with riboflavin and UVA irradiation in pellucid marginal degeneration. J Refract Surg 26:375–377. https://doi.org/10.3928/1081597X-20100114-03. (PMID: 10.3928/1081597X-20100114-0320128533)
Bayraktar S, Cebeci Z, Oray M, Alparslan N (2015) Corneal collagen cross-linking in pellucid marginal degeneration: 2 patients, 4 eyes. Case Rep Ophthalmol Med 2015:1–4. https://doi.org/10.1155/2015/840687. (PMID: 10.1155/2015/840687)
Spadea L, Maraone G, Cagini C (2016) Sliding keratoplasty followed by transepithelial iontophoresis collagen cross-linking for pellucid marginal degeneration. J Refract Surg 32:47–50. https://doi.org/10.3928/1081597X-20151119-02. (PMID: 10.3928/1081597X-20151119-0226812714)
Pircher N, Lammer J, Holzer S, Gschließer A, Schmidinger G et al (2019) Corneal crosslinking for pellucid marginal degeneration. J Cataract Refract Surg 45(8):1163–1167. https://doi.org/10.1016/j.jcrs.2019.03.018. (PMID: 10.1016/j.jcrs.2019.03.01831272773)
Steppat MH, Raiskup-Wolf F, Sporl E et al (2008) Collagen cross linking in patients with pellucid marginal corneal degeneration (PMD). Invest Ophthalmol Vis Sci 49:4342.
Stojanovic A, Zhang J, Chen X et al (2010) Topography-guided transepithelial surface ablation followed by corneal collagen cross-linking performed in a single combined procedure for the treatment of keratoconus and pellucid marginal degeneration. J Refract Surg 26:145–152. https://doi.org/10.3928/1081597X-20100121-10. (PMID: 10.3928/1081597X-20100121-1020163079)
Koc M, Kosekahya P, Inanc M, Tekin K (2019) Corneal crosslinking in a case with Axenfeld-Rieger syndrome and unilateral pellucid marginal degeneration. Ther Adv Ophthalmol 11:251584141882228. https://doi.org/10.1177/2515841418822288. (PMID: 10.1177/2515841418822288)
Lamarca J, Salvador-Culla B, Fernández-Vega C, Barraquer RI (2018) Long-term results of corneal cross-linking for Terrien’s marginal degeneration. J Refract Surg 34:424–429. https://doi.org/10.3928/1081597X-20180426-01. (PMID: 10.3928/1081597X-20180426-0129889297)
Elling M, Kersten-Gomez I, Dick HB (2017) Photorefractive intrastromal corneal crosslinking for the treatment of myopic refractive errors: six-month interim findings. J Cataract Refract Surg 43:789–795. https://doi.org/10.1016/j.jcrs.2017.03.036. (PMID: 10.1016/j.jcrs.2017.03.03628732613)
Stodulka P, Halasova Z, Slovak M et al (2020) Photorefractive intrastromal crosslinking for correction of hyperopia: 12-month results. J Cataract Refract Surg 46:434–440. https://doi.org/10.1097/j.jcrs.0000000000000074. (PMID: 10.1097/j.jcrs.000000000000007432142499)
Kanellopoulos AJ (2014) Novel myopic refractive correction with transepithelial very high-fluence collagen cross-linking applied in a customized pattern: early clinical results of a feasibility study. Clin Ophthalmol 8:697–702. https://doi.org/10.2147/OPTH.S59934. (PMID: 10.2147/OPTH.S59934247412893984063)
O’Brart DPS, Patel P, Lascaratos G et al (2015) Corneal Cross-linking to halt the progression of keratoconus and corneal ectasia: seven-year follow-up. Am J Ophthalmol 160:1154–1163. https://doi.org/10.1016/J.AJO.2015.08.023. (PMID: 10.1016/J.AJO.2015.08.02326307513)
Wollensak G, Spoerl E (2004) Collagen crosslinking of human and porcine sclera. J Cataract Refract Surg 30:689–695. https://doi.org/10.1016/j.jcrs.2003.11.032. (PMID: 10.1016/j.jcrs.2003.11.03215050269)
Saim Khan M, Basit I, Ishaq M et al (2016) Corneal collagen cross linking (CXL) in treatment of pseudophakic bullous keratopathy. Pakistan J Med Sci 32:965–968. https://doi.org/10.12669/pjms.324.10138. (PMID: 10.12669/pjms.324.10138)
Bottós KM, Hofling-Lima AL, Barbosa MC et al (2010) Effect of collagen cross-linking in stromal fibril organization in edematous human corneas. Cornea 29:789–793. https://doi.org/10.1097/ICO.0b013e3181bd9f12. (PMID: 10.1097/ICO.0b013e3181bd9f1220489599)
Arora R, Manudhane A, Saran RK, Goyal J, Goyal G, Gupta D (2013) Role of corneal collagen cross-linking in pseudophakic bullous keratopathy: a clinicopathological study. Ophthalmology 120(12):2413–2418. https://doi.org/10.1016/J.OPHTHA.2013.07.038. (PMID: 10.1016/J.OPHTHA.2013.07.03823953101)
Ucakhan OO, Saglik A (2014) Outcome of two corneal collagen crosslinking methods in bullous keratopathy due to Fuchs’ endothelial dystrophy. Case Rep Med 2014. https://doi.org/10.1155/2014/463905.
Wollensak G, Aurich H, Wirbelauer C, Pham DT (2009) Potential use of riboflavin/UVA cross-linking in bullous keratopathy. Ophthalmic Res 41:114–117. https://doi.org/10.1159/000187630. (PMID: 10.1159/00018763019122475)
Arora R, Gupta D, Goyal JL, Jain P (2012) Results of corneal collagen cross-linking in pediatric patients. J Refract Surg 28:759–762. https://doi.org/10.3928/1081597X-20121011-02. (PMID: 10.3928/1081597X-20121011-0223347368)
Gharaee H, Ansari-Astaneh MR, Armanfar F (2011) The effects of riboflavin/ultraviolet: a corneal cross-linking on the signs and symptoms of bullous keratopathy. Middle East Afr J Ophthalmol 18(1):58–60. https://doi.org/10.4103/0974-9233.75889. (PMID: 10.4103/0974-9233.75889215727363085154)
Kasai K, Kato N, Den S et al (2019) A prospective, randomized clinical study comparing accelerated corneal collagen crosslinking with 5% NaCl hypertonic saline for bullous keratopathy in Asian eyes. Med (United States) 98. https://doi.org/10.1097/MD.0000000000018256.
Cordeiro Barbosa MMV, Barbosa JB, Hirai FE, Hofling-Lima AL (2010) Effect of cross-linking on corneal thickness in patients with corneal edema. Cornea 29:613–617. https://doi.org/10.1097/ICO.0b013e3181c296c2. (PMID: 10.1097/ICO.0b013e3181c296c220458230)
Ghanem RC, Santhiago MR, Berti TB et al (2010) Collagen crosslinking with riboflavin and ultraviolet-a in eyes with pseudophakic bullous keratopathy. J Cataract Refract Surg 36:273–276. https://doi.org/10.1016/j.jcrs.2009.07.041. (PMID: 10.1016/j.jcrs.2009.07.04120152609)
Kozobolis V, Labiris G, Gkika M et al (2010) UV-A collagen cross-linking treatment of bullous keratopathy combined with corneal ulcer. Cornea 29:235–238. https://doi.org/10.1097/ICO.0b013e3181a81802. (PMID: 10.1097/ICO.0b013e3181a8180220023590)
Choy BNK, Ng ALK, Zhu MM et al (2020) Randomized control trial on the effectiveness of collagen cross-linking on bullous keratopathy. Cornea 39:1341–1347. https://doi.org/10.1097/ICO.0000000000002395. (PMID: 10.1097/ICO.000000000000239533017120)
Iseli HP, Thiel MA, Hafezi F, Kampmeier J, Seiler T (2008) Ultraviolet a/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea 27(5):590–594. https://doi.org/10.1097/ICO.0b013e318169d698. (PMID: 10.1097/ICO.0b013e318169d69818520510)
Mattila JS, Korsbäck A, Krootila K, Holopainen JM (2013) Treatment of Pseudomonas aeruginosa keratitis with combined corneal cross-linking and human amniotic membrane transplantation. Acta Ophthalmol 91(5). https://doi.org/10.1111/aos.12115.
Said DG, Elalfy MS, Gatzioufas Z et al (2014) Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting. Ophthalmology 121(7):1377–1382. https://doi.org/10.1016/j.ophtha.2014.01.011. (PMID: 10.1016/j.ophtha.2014.01.01124576886)
Knyazer B, Krakauer Y, Baumfeld Y, Lifshitz T, Kling S, Hafezi F (2018) Accelerated corneal cross-linking with photoactivated chromophore for moderate therapy-resistant infectious keratitis. Cornea 37(4):528–531. https://doi.org/10.1097/ICO.0000000000001498. (PMID: 10.1097/ICO.000000000000149829300262)
Idrus EA, Utti EM, Mattila JS, Krootila K (2019) Photoactivated chromophore corneal cross-linking (PACK-CXL) for treatment of severe keratitis. Acta Ophthalmol 97(7):721–726. https://doi.org/10.1111/aos.14001. (PMID: 10.1111/aos.1400130593737)
Uddaraju M, Mascarenhas J, Das MR et al (2015) Corneal cross-linking as an adjuvant therapy in the management of recalcitrant deep stromal fungal keratitis: a randomized trial. Am J Ophthalmol 160(1):131–134.e5. https://doi.org/10.1016/j.ajo.2015.03.024.
Martinez JD, Arboleda A, Naranjo A et al (2019) Long-term outcomes of riboflavin photodynamic antimicrobial therapy as a treatment for infectious keratitis. Am J Ophthalmol Case Rep 15:100481. https://doi.org/10.1016/j.ajoc.2019.100481. (PMID: 10.1016/j.ajoc.2019.100481311988866556526)
Makdoumi K, Mortensen J, Crafoord S (2010) Infectious keratitis treated with corneal crosslinking. Cornea 29:1353–1358. https://doi.org/10.1097/ICO.0b013e3181d2de91. (PMID: 10.1097/ICO.0b013e3181d2de9121102196)
Makdoumi K, Goodrich R, Bäckman A (2017) Photochemical eradication of methicillin-resistant Staphylococcus aureus by blue light activation of riboflavin. Acta Ophthalmol 95:498–502. https://doi.org/10.1111/aos.13409. (PMID: 10.1111/aos.1340928205348)
Price MO, Tenkman LR, Schrier A, Fairchild KM, Trokel SL, Price FW (2012) Photoactivated riboflavin treatment of infectious keratitis using collagen cross-linking technology. J Refract Surg 28(10):706–713. https://doi.org/10.3928/1081597X-20120921-06. (PMID: 10.3928/1081597X-20120921-0623062001)
Ferrari G, Iuliano L, Viganò M, Rama P (2013) Impending corneal perforation after collagen cross-linking for herpetic keratitis. J Cataract Refract Surg 39:638–641. https://doi.org/10.1016/j.jcrs.2013.02.006. (PMID: 10.1016/j.jcrs.2013.02.00623522585)
Khalili MR, Jahadi HR, Karimiarimi M, Yasemi M (2017) Corneal collagen cross-linking for treatment of bacterial and herpetic keratitis. J Clin Diagn Res 11(7):NC12–NC16. https://doi.org/10.7860/JCDR/2017/24863.10253. (PMID: 10.7860/JCDR/2017/24863.10253288929495583818)
Bamdad S, Malekhosseini H, Khosravi A (2015) Ultraviolet A/riboflavin collagen cross-linking for treatment of moderate bacterial corneal ulcers. Cornea 34:402–406. https://doi.org/10.1097/ICO.0000000000000375. (PMID: 10.1097/ICO.000000000000037525710507)
Arance-Gil Á, Gutiérrez-Ortega AR, Villa-Collar C, Nieto-Bona A, Lopes-Ferreira D, González-Méijome JM (2014) Corneal cross-linking for Acanthamoeba keratitis in an orthokeratology patient after swimming in contaminated water. Contact Lens Anterior Eye 37(3):224–227. https://doi.org/10.1016/j.clae.2013.11.008. (PMID: 10.1016/j.clae.2013.11.00824355444)
Kymionis GD, Tsoulnaras KI, Liakopoulos DA, Skatharoudi CA, Grentzelos MA, Tsakalis NG (2016) Corneal stromal demarcation line depth following standard and a modified high intensity corneal cross-linking protocol. J Refract Surg 32(4):218–222. https://doi.org/10.3928/1081597X-20160216-01. (PMID: 10.3928/1081597X-20160216-0127070227)
Nateghi Pettersson M, Lagali N, Mortensen J, Jofré V, Fagerholm P (2019) High fluence PACK-CXL as adjuvant treatment for advanced Acanthamoeba keratitis. Am J Ophthalmol Case Reports 15. https://doi.org/10.1016/j.ajoc.2019.100499.
Atalay HT, Dogruman-Al F, Sarzhanov F et al (2018) Effect of riboflavin/rose Bengal-mediated PACK-CXL on Acanthamoeba trophozoites and cysts in vitro. Curr Eye Res 43(11):1322–1325. https://doi.org/10.1080/02713683.2018.1501074. (PMID: 10.1080/02713683.2018.150107430021467)
Reviglio VE, Osaba M, Sambuelli G, Kuo IC (2017) Phototoxic effect of topical fluoroquinolones administered before corneal crosslinking in a murine model. J Ocul Pharmacol Ther 33:73–78. https://doi.org/10.1089/jop.2016.0060. (PMID: 10.1089/jop.2016.006028106466)
Kanellopoulos J, Asimellis G, Karabatsas C (2014) Comparison of prophylactic higher fluence corneal cross-linking to control, in myopic LASIK, one year results. Clin Ophthalmol 8:2373. https://doi.org/10.2147/OPTH.S68372. (PMID: 10.2147/OPTH.S68372254732644251572)
Robert MC, Arafat SN, Ciolino JB (2014) Collagen cross-linking of the Boston keratoprosthesis donor carrier to prevent corneal melting in high-risk patients. Eye Contact Lens 40(6):376–381. https://doi.org/10.1097/ICL.0000000000000081. (PMID: 10.1097/ICL.0000000000000081253209578487267)
Zarei-Ghanavati S, Irandoost F (2015) Treatment of refractory keratitis after a Boston type I keratoprosthesis with corneal collagen cross-linking. Cornea 34(9):1161–1163. https://doi.org/10.1097/ICO.0000000000000509. (PMID: 10.1097/ICO.000000000000050926114820)
Tóth G, Bucher F, Siebelmann S et al (2016) In situ corneal cross-linking for recurrent corneal melting after boston type 1 keratoprosthesis. Cornea 35(6):884–887. https://doi.org/10.1097/ICO.0000000000000830. (PMID: 10.1097/ICO.000000000000083027032020)
Richoz O, Moore J, Hafezi F, Moore T (2015) Corneal cross-linking as an adjuvant therapy in the management of recalcitrant deep stromal fungal keratitis: a randomized trial. Am J Ophthalmol 160:616–617. https://doi.org/10.1016/J.AJO.2015.06.014. (PMID: 10.1016/J.AJO.2015.06.01426160699)
Wei A, Wang K, Wang Y et al (2019) Evaluation of corneal cross-linking as adjuvant therapy for the management of fungal keratitis. Graefes Arch Clin Exp Ophthalmol 257:1443–1452. https://doi.org/10.1007/S00417-019-04314-1. (PMID: 10.1007/S00417-019-04314-131041523)
Richoz O, Kling S, Hoogewoud F et al (2014) Antibacterial efficacy of accelerated photoactivated chromophore for keratitis-corneal collagen cross-linking (PACK-CXL). J Refract Surg 30:850–854. https://doi.org/10.3928/1081597X-20141118-01. (PMID: 10.3928/1081597X-20141118-0125437485)
Lamarca J, Vilaplana F, Nadal J et al (2016) Queratitis fúngica por Colletotrichum gloeosporioides resistente a tratamiento. Arch Soc Esp Oftalmol 91:97–101. https://doi.org/10.1016/j.oftal.2015.07.008. (PMID: 10.1016/j.oftal.2015.07.00826601974)
Thakur A, Gupta A, Handa S (2019) Application of photoactivated chromophore for infectious keratitis-corneal collagen crosslinking for fungal phaco-tunnel infection. Indian J Ophthalmol 67:1700. https://doi.org/10.4103/ijo.IJO_123_19. (PMID: 10.4103/ijo.IJO_123_19315465176786139)
Taechajongjintana M, Kasetsuwan N, Reinprayoon U, et al (2018) Effectiveness of voriconazole and corneal cross-linking on Phialophora verrucosa keratitis: a case report. J Med Case Rep 12. https://doi.org/10.1186/S13256-018-1765-1.
Özbek-Uzman S, Burcu A, Yalnız-Akkaya Z et al (2018) Candida parapsilosis infection after crescentic lamellar wedge resection in pellucid marginal degeneration. Turkish J Ophthalmol 48:142–145. https://doi.org/10.4274/TJO.23865. (PMID: 10.4274/TJO.23865)
Buchta V, Nekolová J, Jirásková N et al (2019) Fungal keratitis caused by Colletotrichum dematium: case study and review. Mycopathologia 184:441–453. https://doi.org/10.1007/s11046-019-00335-w. (PMID: 10.1007/s11046-019-00335-w30949880)
Kashiwabuchi RT, Carvalho FRS, Khan YA et al (2011) Assessing efficacy of combined riboflavin and UV-A light (365 nm) treatment of acanthamoeba trophozoites. Investig Ophthalmol Vis Sci 52:9333–9338. https://doi.org/10.1167/iovs.11-8382. (PMID: 10.1167/iovs.11-8382)
Del Buey MA, Cristóbal JA, Casas P et al (2012) Evaluation of in vitro efficacy of combined riboflavin and ultraviolet A for Acanthamoeba isolates. Am J Ophthalmol 153:399–404. https://doi.org/10.1016/j.ajo.2011.07.025. (PMID: 10.1016/j.ajo.2011.07.02521992713)
Lamy R, Chan E, Good SD et al (2016) Riboflavin and ultraviolet A as adjuvant treatment against Acanthamoeba cysts. Clin Exp Ophthalmol 44:181–187. https://doi.org/10.1111/ceo.12644. (PMID: 10.1111/ceo.12644263552734786490)
Berra M, Galperín G, Boscaro G et al (2013) Treatment of acanthamoeba keratitis by corneal cross-linking. Cornea 32:174–178. https://doi.org/10.1097/ICO.0b013e31825cea99. (PMID: 10.1097/ICO.0b013e31825cea9922929160)
Richoz O, Gatzioufas Z, Hafezi F (2013) Corneal collagen cross-linking for the treatment of acanthamoeba keratitis. Cornea 32:2013. https://doi.org/10.1097/ICO.0b013e31829a689e. (PMID: 10.1097/ICO.0b013e31829a689e)
Demirci G, Ozdamar A (2013) A case of medication-resistant Acanthamoeba keratitis treated by corneal crosslinking in Turkey. Case Rep Ophthalmol Med 2013:1–4. https://doi.org/10.1155/2013/608253. (PMID: 10.1155/2013/608253)
Kymionis GD, Kouroupaki AI, Liakopoulos DA et al (2016) Multiorganism, drug-resistant keratitis treated by corneal crosslinking. Eur J Ophthalmol 26:1–4. https://doi.org/10.5301/ejo.5000755. (PMID: 10.5301/ejo.5000755)
Kymionis GD, Portaliou DM, Bouzoukis DI et al (2007) Herpetic keratitis with iritis after corneal crosslinking with riboflavin and ultraviolet A for keratoconus. J Cataract Refract Surg 33:1982–1984. https://doi.org/10.1016/J.JCRS.2007.06.036. (PMID: 10.1016/J.JCRS.2007.06.03617964410)
Yuksel N, Bilgihan K, Hondur AM (2011) Herpetic keratitis after corneal collagen cross-linking with riboflavin and ultraviolet-a for progressive keratoconus. Int Ophthalmol 31:513–515. https://doi.org/10.1007/s10792-011-9489-x. (PMID: 10.1007/s10792-011-9489-x22139351)
Sitaula S, Singh SK, Gurung A (2019) Bilateral viral keratitis following corneal collagen crosslinking for progressive keratoconus. J Ophthalmic Inflamm Infect 9:7–10. https://doi.org/10.1186/s12348-019-0185-8. (PMID: 10.1186/s12348-019-0185-8)
Potti S, Bagad P, Khatib N, Bevara A (2020) Precipitation of herpetic stromal keratitis after collagen cross-linking for keratoconus. Indian J Ophthalmol 68:207. https://doi.org/10.4103/ijo.IJO. (PMID: 10.4103/ijo.IJO318565206951170)
Hou YC, Chen CC, Wang IJ, Hu FR (2004) Recurrent herpetic keratouveitis following YAG laser peripheral iridotomy. Cornea 23:641–642. https://doi.org/10.1097/01.ICO.0000114123.63670.13. (PMID: 10.1097/01.ICO.0000114123.63670.1315257008)
Al-Qarni A, Alharbi M (2015) Herpetic keratitis after corneal collagen cross-linking with riboflavin and ultraviolet-A for keratoconus. Middle East Afr J Ophthalmol 22:389–392. https://doi.org/10.4103/0974-9233.159777. (PMID: 10.4103/0974-9233.159777261804834502188)
Roberts TV, Hodge C, Sutton G, Lawless M (2018) Comparison of Hill-radial basis function, Barrett universal and current third generation formulas for the calculation of intraocular lens power during cataract surgery. Clin Experiment Ophthalmol 46:240–246. https://doi.org/10.1111/CEO.13034. (PMID: 10.1111/CEO.1303428778114)
Kim MJ, Yu F, Aldave AJ (2013) Microbial keratitis after Boston type I keratoprosthesis implantation: incidence, organisms, risk factors, and outcomes. Ophthalmology 120:2209–2216. https://doi.org/10.1016/J.OPHTHA.2013.05.001. (PMID: 10.1016/J.OPHTHA.2013.05.00123747162)
Hou Y, Le VNH, Tóth G et al (2018) UV light crosslinking regresses mature corneal blood and lymphatic vessels and promotes subsequent high-risk corneal transplant survival. Am J Transplant 18:2873–2884. https://doi.org/10.1111/AJT.14874. (PMID: 10.1111/AJT.14874296730636282984)
Lim WK, Da Soh Z, Choi HKY, Theng JTS (2017) Epithelium-on photorefractive intrastromal cross-linking (PiXL) for reduction of low myopia. Clin Ophthalmol 11:1205–1211. https://doi.org/10.2147/OPTH.S137712. (PMID: 10.2147/OPTH.S137712287210045499923)
Kanellopoulos AJ, Asimellis G (2014) Hyperopic correction: clinical validation with epithelium-on and epithelium-off protocols, using variable fluence and topographically customized collagen corneal crosslinking. Clin Ophthalmol 8:2425–2433. https://doi.org/10.2147/OPTH.S68222. (PMID: 10.2147/OPTH.S68222255062044259508)
Lee H, Yong Kang DS, Ha BJ et al (2017) Comparison of outcomes between combined transepithelial photorefractive keratectomy with and without accelerated corneal collagen cross-linking: a 1-year study. Cornea 36:1213–1220. https://doi.org/10.1097/ICO.0000000000001308. (PMID: 10.1097/ICO.000000000000130828749894)
Kanellopoulos AJ, Asimellis G (2015) Combined laser in situ keratomileusis and prophylactic high-fluence corneal collagen crosslinking for high myopia: two-year safety and efficacy. J Cataract Refract Surg 41:1426–1433. https://doi.org/10.1016/j.jcrs.2014.10.045. (PMID: 10.1016/j.jcrs.2014.10.04526287881)
Ganesh S, Brar S (2015) Clinical outcomes of small incision lenticule extraction with accelerated cross-linking (ReLEx SMILE Xtra) in patients with thin corneas and borderline topography. J Ophthalmol 2015. https://doi.org/10.1155/2015/263412.
Lim EWL, Lim L (2019) Review of laser vision correction (LASIK, PRK and SMILE) with simultaneous accelerated corneal crosslinking - long-term results. Curr Eye Res 44:1171–1180. https://doi.org/10.1080/02713683.2019.1656749. (PMID: 10.1080/02713683.2019.165674931411927)
Whitcher JP, Srinivasan M, Upadhyay MP (2001) Corneal blindness: a global perspective. Bull World Health Organ 79:214–221. https://doi.org/10.1590/S0042-96862001000300009. (PMID: 10.1590/S0042-96862001000300009112856652566379)
Khor WB, Prajna VN, Garg P et al (2018) The Asia cornea society infectious keratitis study: a prospective multicenter study of infectious keratitis in Asia. Am J Ophthalmol 195:161–170. https://doi.org/10.1016/J.AJO.2018.07.040. (PMID: 10.1016/J.AJO.2018.07.04030098351)
Spoerl E, Wollensak G, Seiler T (2004) Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res 29:35–40. https://doi.org/10.1080/02713680490513182. (PMID: 10.1080/0271368049051318215370365)
Kumar V, Lockerbie O, Keil SD et al (2004) Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level. Photochem Photobiol 80:15. https://doi.org/10.1562/2003-12-23-RA-036.1. (PMID: 10.1562/2003-12-23-RA-036.115339215)
Price MO, Price FW (2016) Corneal cross-linking in the treatment of corneal ulcers. Curr Opin Ophthalmol 27:250–255. https://doi.org/10.1097/ICU.0000000000000248. (PMID: 10.1097/ICU.000000000000024826730652)
Davis SA, Bovelle R, Han G, Kwagyan J (2020) Corneal collagen cross-linking for bacterial infectious keratitis. Cochrane database Syst Rev 6. https://doi.org/10.1002/14651858.CD013001.PUB2.
Lamy R, Chan E, Good SD et al (2016) Riboflavin and ultraviolet A as adjuvant treatment against Acanthamoeba cysts. Clin Experiment Ophthalmol 44:181–187. https://doi.org/10.1111/CEO.12644. (PMID: 10.1111/CEO.12644263552734786490)
Kymionis GD, Kouroupaki AI, Liakopoulos DA, et al (2016) Multiorganism, drug-resistant keratitis treated by corneal crosslinking. Eur J Ophthalmol 26. https://doi.org/10.5301/EJO.5000755.
Srikumaran D, Munoz B, Aldave AJ et al (2014) Long-term outcomes of boston type 1 keratoprosthesis implantation: a retrospective multicenter cohort. Ophthalmology 121:2159–2164. https://doi.org/10.1016/J.OPHTHA.2014.05.030. (PMID: 10.1016/J.OPHTHA.2014.05.03025017414)
Y Q, P H (2013) Corneal allograft rejection: immunopathogenesis to therapeutics. J Clin Cell Immunol 2013. https://doi.org/10.4172/2155-9899.S9-006.
فهرسة مساهمة: Keywords: Cross-link; Ectasia; Keratoconus; PACK-CXL; Review
المشرفين على المادة: 9007-34-5 (Collagen)
0 (Cross-Linking Reagents)
0 (Photosensitizing Agents)
TLM2976OFR (Riboflavin)
تواريخ الأحداث: Date Created: 20230307 Date Completed: 20230821 Latest Revision: 20230821
رمز التحديث: 20230822
DOI: 10.1007/s00417-023-05994-6
PMID: 36881260
قاعدة البيانات: MEDLINE
الوصف
تدمد:1435-702X
DOI:10.1007/s00417-023-05994-6